剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07666 剂泰科技-P

已收盘 11-09 16:08:05

11.130

+0.140

+1.27%

最高11.500	最低10.990	成交量230.35万
今开10.990	昨收10.990	日振幅4.64%
总市值131.67亿	流通市值120.54亿	总股本11.83亿
成交额2,602万	换手率0.21%	流通股本10.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":11.13,"timestamp":1794211685008,"preClose":10.99,"halted":0,"volume":2303500,"delay":0,"changeRate":0.012738853503184764,"floatShares":1083000000,"shares":1183000000,"eps":-0.5474337834044288,"marketStatus":"已收盘","change":0.14,"latestTime":"11-09 16:08:05","open":10.99,"high":11.5,"low":10.99,"amount":26016130,"amplitude":0.046406,"askPrice":11.13,"askSize":500,"bidPrice":11.07,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.40430681889467407,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794274200000},"marketStatusCode":5,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":10.99,"openAndCloseTimeList":[[1794187800000,1794196800000],[1794200400000,1794211200000]],"volumeRatio":0.557198,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666","defaultTab":"news","newsList":[{"id":"1107007731","title":"剂泰科技-P更新10月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1107007731","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107007731?lang=zh_cn&edition=full","pubTime":"2026-11-04 18:47","pubTimestamp":1793789243,"startTime":"0","endTime":"0","summary":"2026年11月4日，剂泰科技(北京)股份有限公司发布2026年10月证券变动月报。报告显示，公司在本月无新发行或回购股份，也未进行股份注销或库藏变动。报告期内，普通股数量为99,587,739股，对应注册股本人民币9,958,773.90元；H股数量为1,083,110,111股，对应注册股本人民币108,311,011.10元。两类股份数目及相应注册股本与上月底保持一致。本月底公司法定/注册股本总额为人民币118,269,785元。公司确认符合香港联交所相关公众持股量要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680084393","title":"港股异动 | 剂泰科技-P(07666)涨超9% 获纳入港交所人工智能指数 公司平台化变现潜力尚未被充分定价","url":"https://stock-news.laohu8.com/highlight/detail?id=2680084393","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680084393?lang=zh_cn&edition=full","pubTime":"2026-11-04 14:32","pubTimestamp":1793773943,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P午后涨超9%，截至发稿，涨8.67%，报11.16港元，成交额4737.95万港元。消息面上，近日，港交所推出首只人工智能指数。此外，近日剂泰科技官宣与全球制药巨头礼来达成了一项全球交易规模最大的AI驱动肝外LNP递送平台合作。市场分析认为，剂泰科技在AI药物递送领域的先发优势与平台化变现潜力尚未被充分定价，随着指数基金配置需求逐渐释放，以及其自研Biological AI关键基础设施NanoForge平台不断迭代，剂泰科技有望率先实现估值修复。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518262.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07666","QQQ","161631","QDEC","AGIX","NAPR","GK","CPNQ","LCLG","NJUL","KCAI","PBOT","WPAI","KOMP","AQGX","MVPS","QQQX","CHAT","NBDS","QLD","CWC","HEXmain","QQQM","NEWZ","QTOC","TECY","MFIG","FWD","PSQ","ARTY","AIFD","SQQQ","DQJN","AIQU","TQQQ","AIBU","QMAR","OVQ","QQA","QSWN","NJAN","VUSE","QID","TARK","GPIQ","OGIG","TQQY","VXUS","NOCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679223234","title":"剂泰科技-P(07666.HK)获纳入港交所人工智能指数 AI药物递送龙头有望迎价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2679223234","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679223234?lang=zh_cn&edition=full","pubTime":"2026-10-29 15:17","pubTimestamp":1793258277,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114991263","title":"异动解读｜剂泰科技-P盘中上涨5.07%，礼来合作后AiLNP平台价值持续获重估","url":"https://stock-news.laohu8.com/highlight/detail?id=1114991263","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114991263?lang=zh_cn&edition=full","pubTime":"2026-10-29 10:27","pubTimestamp":1793240824,"startTime":"0","endTime":"0","summary":"10月29日，剂泰科技-P盘中上涨5.07%，报12.01港元，成交额2311.97万港元。消息面上，市场继续消化公司与礼来签署的新一代组织特异性LNP递送技术战略合作，带动其AI驱动递送平台商业化价值重估。机构认为，此次合作进一步验证公司AiLNP平台差异化价值，平台先发优势有望持续体现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技异动上涨，礼来合作催化价值重估","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678422439","title":"剂泰科技-P午前涨近6% 机构料公司AiLNP平台价值有望持续体现","url":"https://stock-news.laohu8.com/highlight/detail?id=2678422439","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678422439?lang=zh_cn&edition=full","pubTime":"2026-10-28 11:31","pubTimestamp":1793158260,"startTime":"0","endTime":"0","summary":"近日，剂泰科技宣布与礼来签署战略合作，共同推进新一代组织特异性LNP递送技术。剂泰科技将依托NanoForge驱动的AiLNP平台研发新一代LNP递送技术，礼来投入药物发现、开发及商业化资源推进合作。海通国际认为，此次公司与全球头部药企礼来合作，进一步验证公司AiLNP递送技术和NanoForge平台的差异化价值，获得国际大药企背书。制药行业对肝外递送的需求有望持续释放，公司AiLNP技术平台已形成一定的先发优势，平台价值有望持续体现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-10-28/doc-iniwtxyc9654092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","HK0000165453.HKD","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678439391","title":"港股异动 | 剂泰科技-P(07666.HK)早盘涨近7% AiLNP平台获国际药企背书 平台价值有望持续体现","url":"https://stock-news.laohu8.com/highlight/detail?id=2678439391","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678439391?lang=zh_cn&edition=full","pubTime":"2026-10-28 11:14","pubTimestamp":1793157289,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","HK0000165453.HKD","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137165869","title":"异动解读｜剂泰科技-P盘中上涨5.32%，礼来LNP合作催化持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1137165869","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137165869?lang=zh_cn&edition=full","pubTime":"2026-10-28 10:09","pubTimestamp":1793153360,"startTime":"0","endTime":"0","summary":"10月28日，剂泰科技-P盘中上涨5.32%，报11.49港元，成交额2593.56万港元。消息面上，市场仍在持续消化公司此前与礼来达成的新一代组织特异性LNP递送技术战略合作，重估其AI驱动递送平台的商业化价值。合作依托其AI驱动AiLNP平台，聚焦新型脂质纳米粒架构发现与优化，平台验证意义对股价形成支撑。剂泰科技（北京）股份有限公司是一家主要从事人工智能纳米材料创新的中国公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技盘中上涨，礼来LNP合作持续催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678521771","title":"港股异动 | 剂泰科技-P(07666.HK)涨近8% 携手礼来推进AI驱动肝外LNP递送平台合作 公司有望承接更多产业增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2678521771","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678521771?lang=zh_cn&edition=full","pubTime":"2026-10-26 15:12","pubTimestamp":1792998746,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175810872","title":"异动解读｜剂泰科技-P盘中上涨5.1%，礼来LNP合作余温延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1175810872","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175810872?lang=zh_cn&edition=full","pubTime":"2026-10-26 13:45","pubTimestamp":1792993537,"startTime":"0","endTime":"0","summary":"10月26日，剂泰科技-P盘中上涨5.1%，报11.12港元，成交额3615.21万港元。消息面上，公司此前与礼来达成新一代组织特异性LNP递送技术战略合作，市场仍在围绕该项大单重新评估其AI递送平台商业化价值。已披露条款显示，公司将收取逾千万美元首付款，并有资格获得最高约11亿美元开发、监管及商业里程碑付款，以及个位数分级特许权使用费；合作依托其AI驱动AiLNP平台，聚焦新型脂质纳米粒架构发现与优化。尽管此前股价一度因资金分歧回落，但合作的平台验证意义仍对股价形成支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技盘中上涨，礼来合作余温持续","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103553398","title":"异动解读｜剂泰科技-P盘中下跌5.28%，瑞银降至中性后礼来合作分歧延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1103553398","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103553398?lang=zh_cn&edition=full","pubTime":"2026-10-23 09:37","pubTimestamp":1792719448,"startTime":"0","endTime":"0","summary":"10月23日，剂泰科技-P盘中下跌5.28%，报10.07港元，成交额634.93万港元。消息面上，瑞银将公司评级下调至中性，目标价27元人民币；与此同时，公司此前与礼来达成的新一代组织特异性LNP递送技术战略合作虽具备平台验证意义，但利好披露后资金分歧仍在延续。已披露合作条款显示，剂泰科技将收取逾千万美元首付款，并有资格获得最高约11亿美元开发、监管及商业里程碑付款，以及个位数分级特许权使用费，合作依托其AI驱动AiLNP平台推进新型LNP架构发现与优化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技盘中走低，瑞银降级礼来合作分歧延续","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169280209","title":"异动解读｜剂泰科技-P盘中下跌6.26%，礼来11亿美元LNP合作后资金分歧延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1169280209","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169280209?lang=zh_cn&edition=full","pubTime":"2026-10-22 09:47","pubTimestamp":1792633650,"startTime":"0","endTime":"0","summary":"10月22日，剂泰科技-P盘中下跌6.26%，报10.78港元，成交额845.96万港元。消息面上，公司日前宣布与礼来达成新一代组织特异性LNP递送技术战略合作，但在重大利好落地后，市场交易重心转向兑现节奏与估值消化，资金分歧有所延续。已披露条款显示，公司将收取逾千万美元首付款，并有资格获得最高约11亿美元开发、监管及商业里程碑付款，以及个位数分级特许权使用费；合作依托其AI驱动AiLNP平台，聚焦新型脂质纳米粒架构发现与优化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技盘中下跌，LNP合作后资金分歧延续","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677642431","title":"【券商聚焦】中泰国际：创新药与医疗AI技术出海捷报频传","url":"https://stock-news.laohu8.com/highlight/detail?id=2677642431","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677642431?lang=zh_cn&edition=full","pubTime":"2026-10-21 13:28","pubTimestamp":1792560508,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际表示，中国创新药企业继2026年上半年出海金额同比增加36%至1,200亿美元后，下半年仍然捷报频出。港股上市的企业中，9月恒瑞医药9月与诺和诺德达成总额最高26亿美元的授权协议后，创新药龙头翰森制药与AI技术平台开发商剂泰科技近日分别与礼来及罗氏达成战略合作。该机构重申聚焦创新药龙头观点，并看好中国AI制药新技术。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994121","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0244354667.USD","LU0455707207.USD","LU1807302812.USD","LU2488822045.USD","01177","BK1521","LU0359202008.SGD","LU1188198961.HKD","00013","BK1161","LU0502904849.HKD","LU0463099449.HKD","LU0149534421.HKD","IE00BZ08YT58.USD","BK1574","01276","IE00B5MMRT66.SGD","LU2097828557.USD","IE00BZ08YS42.EUR","03692","LU1951186391.HKD","LU2242644610.SGD","LU0607220059.USD","159992","SG9999004220.SGD","LU0828237510.HKD","LU1023057109.AUD","01801","06160","IBBQ","KURE","LU1303224171.USD","LU1813983027.USD","LU1831875114.USD","LNGR","LU0140636845.USD","01093","06978","LU0072913022.USD","LU0228659784.USD","LU0067412154.USD","LU1226287792.SGD","150261","LU1008478684.HKD","MEDX","IE00B031HY20.USD","LU1226287875.USD","KCE","LU1719994722.HKD","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677641988","title":"剂泰科技-P盘中涨超10% 11亿美元拿下礼来AI-LNP订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2677641988","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677641988?lang=zh_cn&edition=full","pubTime":"2026-10-21 11:54","pubTimestamp":1792554840,"startTime":"0","endTime":"0","summary":"模拟交易客户端剂泰科技-P盘中涨超10%，截至发稿，股价上涨2.41%，报11.46港元，成交额8413.10万港元。10月19日，剂泰科技-P与全球知名跨国药企礼来达成了一项全球交易规模最大的AI驱动肝外LNP递送平台合作，同时也是中国首个生成式AI-LNP平台战略合作。近年来，剂泰科技创新自研的Biological AI关键基础设施NanoForge平台已获得了国际专业投资机构和头部跨国药企的广泛认可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-10-21/doc-inivyaat6248702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGIX","ARTY","07666","QTOC","HK0000165453.HKD","AIPO","VTHR","CHAT","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116028112","title":"异动解读｜剂泰科技-P盘中上涨5.81%，礼来11亿美元LNP合作持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1116028112","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116028112?lang=zh_cn&edition=full","pubTime":"2026-10-21 09:32","pubTimestamp":1792546373,"startTime":"0","endTime":"0","summary":"10月21日，剂泰科技-P盘中上涨5.81%，报12.04港元，成交额1367.02万港元。消息面上，公司日前宣布与礼来达成新一代组织特异性LNP递送技术战略合作，市场仍在消化这一重大合作带来的平台价值重估预期。根据已披露条款，剂泰科技将获得逾千万美元首付款，并有资格收取最高约11亿美元开发、监管及商业里程碑付款，以及个位数分级特许权使用费。合作将依托其AI驱动AiLNP平台，聚焦新型LNP架构发现与优化，用于提升组织特异性递送能力。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技盘中拉升，礼来11亿美元合作发酵","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188650663","title":"异动解读｜剂泰科技-P盘中下跌5.12%，礼来11亿美元LNP合作落地后资金分歧加大","url":"https://stock-news.laohu8.com/highlight/detail?id=1188650663","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188650663?lang=zh_cn&edition=full","pubTime":"2026-10-20 15:15","pubTimestamp":1792480537,"startTime":"0","endTime":"0","summary":"10月20日，剂泰科技-P盘中下跌5.12%，报11.31港元，成交额1.24亿港元。消息面上，公司此前一日宣布与礼来达成新一代组织特异性LNP递送技术战略合作，首付款为逾千万美元，并有资格收取最高约11亿美元开发、监管及商业里程碑付款，以及个位数分级特许权使用费。该合作聚焦AI驱动的AiLNP平台，用于发现和优化新型脂质纳米粒递送方案。尽管公司当日开盘一度受此提振走强，但盘中转跌，反映资金在重大利好兑现后的博弈加剧。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技盘中异动，礼来合作后资金博弈加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676063077","title":"早盘竞价跳涨15% 剂泰科技（07666）站上Biological AI风口，11亿美元拿下礼来AI-LNP平台订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2676063077","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676063077?lang=zh_cn&edition=full","pubTime":"2026-10-20 09:25","pubTimestamp":1792459528,"startTime":"0","endTime":"0","summary":"10月19日，剂泰科技-P与全球知名跨国药企礼来达成了一项全球交易规模最大的AI驱动肝外LNP递送平台合作，同时也是中国首个生成式AI-LNP平台战略合作。10月20日，剂泰科技股价在早盘竞价阶段最高涨近15%，显示出市场对上述利好的积极反馈。而此次与礼来达成的重磅战略合作，无疑是剂泰NanoForge平台价值加速兑现的又一具象化表现。近年来，剂泰科技创新自研的Biological AI关键基础设施NanoForge平台已获得了国际专业投资机构和头部跨国药企的广泛认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509166.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","ARTY","AIPO","CHAT","BK1161","07666","HK0000165453.HKD","VTHR","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676630724","title":"港股异动 | 剂泰科技-P(07666)高开逾6% 与礼来达成LNP递送合作 里程碑最高11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676630724","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676630724?lang=zh_cn&edition=full","pubTime":"2026-10-20 09:23","pubTimestamp":1792459433,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P高开逾6%，截至发稿，涨6.46%，报12.69港元，成交额231.68万港元。消息面上，10月19日，剂泰科技发布公告称，已与礼来达成战略合作，聚焦新型脂质纳米粒递送解决方案，用于治疗方式的组织特异性递送。根据协议条款，剂泰科技将收取一笔逾千万美元的首付款，并有资格收取总额最高约11亿美元的开发、监管及商业里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["HK0000165453.HKD","VXUS","BK1161","KCAI","BK4588","07666","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676500681","title":"剂泰科技-P(07666.HK)：与礼来达成战略合作以推进新一代组织特异性LNP递送技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2676500681","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676500681?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:48","pubTimestamp":1792406891,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","HK0000165453.HKD","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127188768","title":"剂泰科技-P（07666）宣布与礼来达成新一代组织特异性LNP递送技术战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1127188768","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127188768?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:21","pubTimestamp":1792405276,"startTime":"0","endTime":"0","summary":"2026年10月19日，剂泰科技（北京）股份有限公司公布，其已与Eli Lilly and Company（礼来）签署战略合作协议，双方将共同开发新型脂质纳米粒递送解决方案，目标是实现治疗方式的组织特异性递送。双方合作旨在发现并优化具有更高组织特异性的LNP架构，拓展其在多疾病领域的应用。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675455420","title":"港股异动 | 剂泰科技-P(07666.HK)早盘涨近8% 医药十五五规划提出打造AI制药高价值应用场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2675455420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675455420?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:41","pubTimestamp":1792114901,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","07666","BK1191","HK0000165453.HKD","BK1515","01477","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.3482},{"period":"3month","weight":-0.0117},{"period":"6month","weight":0.0467},{"period":"ytd","weight":0.0467}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"剂泰科技（北京）股份有限公司是一家主要从事人工智能（AI）纳米材料创新的中国公司。NanoForge是该公司的人工智能驱动纳米科技创新体系的基础，涵盖脂质库、人工智能基础模型、METiS AI智能体、量子化学与分子动力学模拟及人工智能驱动的筛选平台。该公司开发了三大专业的解决方案，包括AiTEM、AiLNP及AiRNA平台，用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}